Metformin in Obese Children and Adolescents

PHASE3CompletedINTERVENTIONAL
Enrollment

62

Participants

Timeline

Start Date

August 31, 2011

Primary Completion Date

August 31, 2015

Study Completion Date

February 28, 2017

Conditions
ObesityInsulin Resistance
Interventions
DRUG

Metformin

Oral administration, 500 mg daily at week 1. Every week metformin dosage increases with 500 mg, to a maximum dose of 1000 mg bid. This maximum dose will be administered till the end of the study.

BEHAVIORAL

Lifestyle intervention

Lifestyle intervention: 18 months physical therapy and dietary advice

Trial Locations (2)

Unknown

Jeroen Bosch Hospital, 's-Hertogenbosch

3430EM

St. Antonius Hospital, Nieuwegein

All Listed Sponsors
collaborator

Jeroen Bosch Ziekenhuis

OTHER

lead

St. Antonius Hospital

OTHER

NCT01487993 - Metformin in Obese Children and Adolescents | Biotech Hunter | Biotech Hunter